Cleared Traditional

K213930 - Brainlab Elements Guide XT

K213930 is an FDA 510(k) clearance for Brainlab Elements Guide XT, manufactured by Brainlab AG. The device is a Class 2 Neurology device with product code QQC cleared through the Traditional 510(k) pathway after a 124-day FDA review.

K213930 · Brainlab AG · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2022
Decision
124d
Days
Class 2
Risk

K213930 is an FDA 510(k) clearance for the Brainlab Elements Guide XT, Guide 3.0. Classified as Brain Stimulation Programming Planning Software. (product code QQC), Class II - Special Controls.

Submitted by Brainlab AG (Munich, DE). The FDA issued a Cleared decision on April 19, 2022 after a review of 124 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5855 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Brainlab AG devices

FDA 510(k) Submission Details - K213930

510(k) Number K213930 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 16, 2021
Decision Date April 19, 2022
Days to Decision 124 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
24d faster than avg
Panel avg: 148d · This submission: 124d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

QQC Device Classification - Class 2, Special Controls

Product Code QQC Brain Stimulation Programming Planning Software.
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5855
Definition The Brain Stimulation Programming Planning Software Is A Prescription Device Intended To Assist In Planning Stimulation Programming For Implanted Brain Stimulators.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.